Hypertrophic cardiomyopathy. Cardiomyocyte ultrastructure, the specific or stereotypic signs

• Published in: Arkhiv patologii Vol. 81; no. 6; p. 5
• Main Authors: Sukhacheva, T V, Serov, R A, Bockeria, L A
• Format: Journal Article
• Language: Russian
• Published: Russia (Federation) 2019
• Subjects: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Humans; Middle Aged; Myocardium; Myocytes, Cardiac; Myofibrils; Ventricular Septum; Young Adult; cardiomyocytes; hypertrophic cardiomyopathy; myofibrillar loss; dystrophic changes; ultrastructure; hypertrophy
• ISSN: 0004-1955
• DOI: 10.17116/patol2019810615

Hypertrophic cardiomyopathy (HCM) is a congenital disease caused by mutations in a number of sarcomere proteins. According to the type of mutation, clinical observations record similar clinical manifestations, myocardial pathological changes, and the timing of manifestation of the disease in HCM patients. To study cardiomyocyte (CMC) ultrastructural changes in the interventricular septum (IVS) of patients with HCM and evaluate their specificity for this pathology. IVS myocardial samples taken from 44 HCM patients aged 18-59 years at IVS myoectomy underwent an electron microscopic study. The diameter of CMCs and their nuclei was measured in semithin sections. A morphometric examination of the IVS myocardium in HCM patients revealed moderate hypertrophy of CMCs and their nuclei, the diameters of which averaged 23.7±4.4 and 5.2±0.9 μm, respectively. The IVS CMCs were characterized by the ultrastructural signs of hypertrophy: the larger size and number of structures ensuring contractile and synthetic functions; the myocytes contained higher amounts of myofibrils, intermyofibrillar mitochondria, granular endoplasmic reticulum cisterns, and free ribosomes. On the contrary, some CMCs had fewer myofibrils in the perinuclear region, which is an adaptive change under hemodynamic overload conditions. In addition, a number of myocytes displayed signs of dystrophic changes: the appearance of lipofuscin granules, myelin figures, phagosomes, lipid droplets, and vacuoles, which can fill all free sarcoplasmic zones. Ultrastructural changes characteristic of hypertrophy were found in IVS CMCs in HCM patients. In addition, there was partial myofibrillar loss and dystrophic changes in a number of myocytes, which are stereotypic compensatory-adaptive changes under hemodynamic overload conditions. All the above-mentioned changes in the CMC ultrastructure are characteristic of myocardial hypertrophy, but not specific for hypertrophic cardiomyopathy.